Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

AbbVie Flags $2.7B R&D Hit, Adjusts Full-Year Profit Forecast

AbbVie Flags $2.7B R&D Hit, Adjusts Full-Year Profit Forecast

AbbVie, a major player in the pharmaceutical industry, has announced a substantial $2.7 billion hit related to acquired in-process research and development (IPR&D) expenses and milestones for the third quarter of 2025. This unexpected development has led the company to revise its full-year earnings per share forecast, reducing it by $1.50 on both ends of the range. The new guidance now stands at $10.38 to $10.58 per share.

NoahAI News10/6/2025
FDA Approves Groundbreaking Cryoablation Treatment for Early-Stage Breast Cancer

FDA Approves Groundbreaking Cryoablation Treatment for Early-Stage Breast Cancer

The U.S. Food and Drug Administration (FDA) has granted approval to IceCure Medical's ProSense, a novel cryoablation system for the treatment of early-stage breast cancer. This landmark decision marks the first time a medical device of this kind has been authorized for local treatment of breast cancer in the United States.

NoahAI News10/6/2025
Ignota Labs Acquires Kronos Bio's Clinical Pipeline, Breathing New Life into Shelved Drug Programs

Ignota Labs Acquires Kronos Bio's Clinical Pipeline, Breathing New Life into Shelved Drug Programs

In a strategic move that highlights the growing trend of rescuing abandoned drug candidates, UK-based Ignota Labs has acquired the clinical pipeline of Kronos Bio. This acquisition, valued at less than $300,000, marks a significant development in the pharmaceutical industry's approach to drug development and asset management.

NoahAI News10/6/2025
Talkspace Expands Mental Health Services with Wisdo Health Acquisition

Talkspace Expands Mental Health Services with Wisdo Health Acquisition

Talkspace, a leading online therapy provider, has acquired Wisdo Health, a social health platform specializing in peer support and coaching services. This strategic move aims to broaden Talkspace's mental health offerings and address the growing need for connection and emotional resilience in an increasingly isolated society.

NoahAI News10/6/2025
Layoffs Continue to Sweep Across Biotech and Pharma Industries

Layoffs Continue to Sweep Across Biotech and Pharma Industries

The pharmaceutical and biotechnology sectors are experiencing another wave of workforce reductions as companies aim to cut costs, extend cash runways, and refocus their pipelines. This trend, which began in 2024, shows no signs of slowing down in 2025.

NoahAI News10/4/2025
Whistleblower Retaliation Allegations Rock NIH Leadership Amid Vaccine Controversy

Whistleblower Retaliation Allegations Rock NIH Leadership Amid Vaccine Controversy

In a series of unprecedented events, several high-ranking officials at the National Institutes of Health (NIH) have been terminated or placed on administrative leave, sparking allegations of whistleblower retaliation and raising concerns about the agency's commitment to scientific integrity under the current administration.

NoahAI News10/4/2025
Precision Neuroscience Unveils Groundbreaking Brain-Computer Interface Study

Precision Neuroscience Unveils Groundbreaking Brain-Computer Interface Study

Precision Neuroscience, a leading developer of brain-computer interfaces (BCIs), has published a landmark study in Nature Biomedical Engineering, showcasing the capabilities of its minimally invasive Layer 7 cortical interface. The research highlights the device's ability to collect high-bandwidth neural data and deliver stimulation without deep tissue penetration, potentially revolutionizing the field of neurotechnology.

NoahAI News10/4/2025
Biopharma Industry Faces Continued Layoffs Amid Restructuring and Strategic Shifts

Biopharma Industry Faces Continued Layoffs Amid Restructuring and Strategic Shifts

The pharmaceutical industry is experiencing a significant wave of layoffs and restructuring as companies grapple with changing market dynamics and strategic priorities. Recent data from Fierce Biotech's Layoff Tracker reveals that the third quarter of 2025 saw 62 layoff rounds, nearly matching the 64 rounds reported in each of the first two quarters. This trend puts 2025 on track to surpass the previous year's total of 192 layoff rounds, with projections suggesting a potential 27% increase by year-end.

NoahAI News10/4/2025
Whistleblower Allegations Rock NIAID as Former Director Jeanne Marrazzo Terminated

Whistleblower Allegations Rock NIAID as Former Director Jeanne Marrazzo Terminated

In a significant development within the pharmaceutical and public health sectors, Dr. Jeanne Marrazzo, the former director of the National Institute of Allergy and Infectious Diseases (NIAID), was formally terminated on Thursday following months of administrative leave. The dismissal comes in the wake of a whistleblower complaint filed by Marrazzo against senior leadership at the Department of Health and Human Services (HHS), alleging retaliation for her stance on scientific integrity and public health policies.

NoahAI News10/3/2025
Amgen's Repatha Shows Promise in Cardiovascular Disease Prevention

Amgen's Repatha Shows Promise in Cardiovascular Disease Prevention

Amgen's cholesterol-lowering drug Repatha (evolocumab) has demonstrated significant potential in preventing cardiovascular events in high-risk patients without prior heart disease, according to recent clinical trial results. This development could expand the drug's reach and solidify its position in the competitive cardiovascular medication market.

NoahAI News10/3/2025
FDA Approval of Jazz and Roche's Combo Therapy Sets New Standard in First-Line Small Cell Lung Cancer Treatment

FDA Approval of Jazz and Roche's Combo Therapy Sets New Standard in First-Line Small Cell Lung Cancer Treatment

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking combination therapy for extensive-stage small cell lung cancer (ES-SCLC), marking a significant advancement in first-line treatment options. Jazz Pharmaceuticals' Zepzelca (lurbinectedin), used in conjunction with Roche's Tecentriq (atezolizumab), has received the green light as a first-line maintenance treatment for ES-SCLC patients who have not progressed after initial induction therapy.

NoahAI News10/3/2025
GoodRx Sees Potential in TrumpRx Partnership and Expands Kroger Collaboration

GoodRx Sees Potential in TrumpRx Partnership and Expands Kroger Collaboration

GoodRx, the prescription drug savings platform, has seen a significant boost in its stock value following two major developments: the announcement of a potential partnership with the newly launched TrumpRx website and an expanded collaboration with national retail pharmacy chain Kroger. These moves come as the pharmaceutical industry braces for changes in drug pricing and distribution models.

NoahAI News10/3/2025
«1...535455...67»